At a glance
Possible toolACQ-11 · Cooperation & exchanges
Authority holder: Federal agency authorizing laboratory directors; military-department Secretaries and Secretary of Defense/DARPA may permit FFRDC directors
Cooperation & exchanges
Mechanism tags describe the source text; they do not expand the authority.
Availability and verificationExpress statutory pathway; award-specific appropriations, available balances, delegations, implementation and approvals not independently verified.
Program process and intake
Checked 2026-10-04 · process documented. Program evidence is separate from legal authority, available funds and transaction approval.
Turn a shared laboratory R&D objective into a defined project and negotiated contributions—not a request for federal cash.
Laboratory CRADA — NRL and DAF examples
- Who this route serves
- Non-federal R&D collaborators; this is not a grant application
- Administering office / routing lead
- Participating laboratory technology-transfer office; DAF T3 provides ORTA services where no local ORTA exists
Direct implementationDAF expressly identifies 15 USC 3710a. These are examples of the CRADA instrument, not a single department-wide intake.
What this evidence label means Process documented; project agreement requiredThe published process was checked; no award or appointment availability is inferred.
Status reference date: 2026-10-04 · research checked 2026-10-04
DAF CRADA process and February 2026 model · Overview; collaborators; model agreementofficial program guidance · Evidence record Program eligibility
Steps and preparation
Funding, limits and authority relationship
Read the official process →
program information: Information and institutional inquiry, not an award application.
Research scope and sources checked
The first program-depth pass checked the cited program pages, notices and legal framework. Evidence is limited to the named routes and source-access notes; it does not establish every implementation of the statute.
What remains unverified
- Project acceptance, specific technical counterpart, IP terms and execution authority remain agreement-specific.
A dated source check is not continuing monitoring. Recheck the linked official notice before preparing a submission. Browse program research →
Funding conditions
- Partner funds may be accepted, retained and used for collaboration; lab supplies authorized in-kind resources.
Read the funding and execution guide
Who contributes what
Need & planning
- Laboratory scientific lead and Office of Research and Technology Applications
Resources
- Laboratory director and sponsoring component budget owner
Approval
- Laboratory director and agency approver as statute/delegation requires
Execution
- Laboratory ORTA, counsel and authorized agreement official
Partners & review
- Industry, universities, nonprofit and government collaborators within eligibility limits
Office links are editorial matches to the original role text, not verified delegations. Composite labels and unmatched actors are preserved.
Coordination pathwayTechnical lead → ORTA/counsel → laboratory director/required agency approval → signed CRADA with contribution and IP schedule.
Actor and execution-role sources
What this research establishes
Legal basisSources linkedLegal sources and instrument limits are recorded.
RequirementsGates recordedRead the requirements for this instrument; applicability depends on the proposed action.
Public fundingRules recordedPartner funds may be accepted, retained and used for collaboration; lab supplies authorized in-kind resources. Office budget figures are separate institutional context, not an allocation to this instrument. Assigned rolesRoles recordedPublic sources describe institutional authority. The instrument identifies approval and execution roles; a specific signature remains transaction-dependent. EngagementProcess sourcedTurn a shared laboratory R&D objective into a defined project and negotiated contributions—not a request for federal cash. Program check: 2026-10-04; see each route for intake status. Confidence: High on express authority and cited conditions; execution assignment is illustrative unless statute expressly names it.
Currentness: GovInfo 2024 Code (includes FY2025 NDAA, P.L. 118-159) read in full for cited provision; targeted FY2026 NDAA P.L. 119-60 amendment/repeal sweep. No claim of complete legislative currency through 2026-10-02; remaining 2026 delta needs counsel validation.
Review scope: Original research target October 2, 2026; no record-specific last-review date supplied. Publication is not legal-currentness certification.